We have tracked over 176 funding programs and $85,622,342 allocated for Alzheimers Disease Research.
| Recent Funding Opportunity |
|---|
| High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional) (apply for RFA AG 22 012) Funding Number: RFA AG 22 012 Agency: National Institutes of Health Funding Amount: $250,000 |
| Alzheimers Disease Research Centers (P50) (apply for RFA AG 10 002) Funding Number: RFA AG 10 002 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| Alzheimer's Disease Initiative - Specialized Supportive Services (ADI-SSS) Project Financed Solely by 2017 Prevention and Public Health Funds (PPHF 2017) (apply for HHS 2017 ACL AOA ALGG 0227) Funding Number: HHS 2017 ACL AOA ALGG 0227 Agency: Department of Health and Human Services, Administration for Community Living Funding Amount: $1,000,000 |
| Systems Biology Approaches to Alzheimers Disease Using Non-mammalian Laboratory Animals (R01) (apply for RFA AG 17 057) Funding Number: RFA AG 17 057 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) (apply for PAR 25 374) Funding Number: PAR 25 374 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed) (apply for RFA AG 21 006) Funding Number: RFA AG 21 006 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| Alzheimers Disease Initiative Specialized Supportive Services (ADI SSS) Project Financed Solely by 2015 Prevention and Public Health Funds (PPHF 2015) (apply for HHS 2015 ACL AOA AL 0104) Funding Number: HHS 2015 ACL AOA AL 0104 Agency: Administration for Community Living Funding Amount: $1,000,000 |
| Planning Grants for Alzheimers Disease Translational Centers for Predictive Drug Development (R34) (apply for RFA AG 14 017) Funding Number: RFA AG 14 017 Agency: National Institutes of Health Funding Amount: $200,000 |
| Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (apply for PAR 21 360) Funding Number: PAR 21 360 Agency: National Institutes of Health Funding Amount: $325,000 |
| FY11 Militarily Relevant Peer Reviewed Alzheimers Disease Research Program (MRPRA) Translational Research Award (apply for W81XWH 11 MRPRA TRA) Funding Number: W81XWH 11 MRPRA TRA Agency: Dept. of the Army USAMRAA Funding Amount: $500,000 |
| Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01) (apply for PAR 17 029) Funding Number: PAR 17 029 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) (apply for PAR 20 156) Funding Number: PAR 20 156 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Alzheimers Disease Supportive Services Program Innovation Cooperative Agreements to Better Serve People with Alzheimer (apply for HHS 2010 AOA AI 1012) Funding Number: HHS 2010 AOA AI 1012 Agency: Administration on Aging Funding Amount: $200,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional) (apply for PAR 18 181) Funding Number: PAR 18 181 Agency: National Institutes of Health Funding Amount: Case Dependent |
| NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (apply for PAR 22 022) Funding Number: PAR 22 022 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01) (apply for PAR 17 047) Funding Number: PAR 17 047 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) (apply for PAR 23 258) Funding Number: PAR 23 258 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed) (apply for RFA AG 25 014) Funding Number: RFA AG 25 014 Agency: National Institutes of Health Funding Amount: $500,000 |
| Alzheimers Disease Core Centers (P30) (apply for RFA AG 15 001) Funding Number: RFA AG 15 001 Agency: National Institutes of Health Funding Amount: $1,000,000 |
| The Role of Apolipoprotein E, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimers Disease (R01) (apply for PA 09 217) Funding Number: PA 09 217 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) (apply for RFA AG 13 019) Funding Number: RFA AG 13 019 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Human Three-Dimensional Cell Model Systems for Alzheimers Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) (apply for RFA NS 19 027) Funding Number: RFA NS 19 027 Agency: National Institutes of Health Funding Amount: $750,000 |
| National Institute on Aging Analysis of Alzheimers Disease Genome Sequencing Project Data U19 (apply for PAR 12 183) Funding Number: PAR 12 183 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (apply for RFA AG 19 003) Funding Number: RFA AG 19 003 Agency: National Institutes of Health Funding Amount: $100,000 |
| Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42) (apply for PAR 17 066) Funding Number: PAR 17 066 Agency: National Institutes of Health Funding Amount: Case Dependent |
Inside USGrants.org Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads